U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07478107) titled 'Molecular Citology to Detect Free Cancer Cells in Peritoneal Fluid' on March 12.

Brief Summary: In gastrointestinal malignancies peritoneal diffusion represent a severe adverse event. Current methodoly including cytology of peritoneal fluid appears insufficient. It's crucial to individuate new technology.

Study Start Date: July 01, 2024

Study Type: OBSERVATIONAL

Condition: Peritoneal Diffusion

Recruitment Status: COMPLETED

Sponsor: University of Campania Luigi Vanvitelli

Information provided by (Responsible Party): Gennaro Galizia, University of Campania Luigi Vanvitelli

Disclaimer: Curated by HT Syndication....